A treatment algorithm for Hepatic Angiomyolipomas: a long-term follow-up study and a systematic review

Completed

• Conditions: benign liver tumor; Mesenchymal tumor; 10019815; 10019818

• Registration Number: NL-OMON44998
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 9

Inclusion Criteria

Eighteen years or older;
Diagnosis of HAML either by MRI, biopsy or after tumor resection;
Previous MRI scan with baseline characteristics for patients who received a non-surgical treatment.

Exclusion Criteria

Contrast allergy;
MRI contraindication (e.g. pacemaker, metal)
Renal failure.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Number of recurrences, growth (size of tumor) or new HAML tumors.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>